Market revenue in 2023 | USD 239.3 million |
Market revenue in 2030 | USD 454.9 million |
Growth rate | 9.6% (CAGR from 2023 to 2030) |
Largest segment | Volumetric infusion pumps |
Fastest growing segment | Insulin Infusion Pumps |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Volumetric Infusion Pumps, Syringe Infusion Pumps, Insulin Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient-Controlled Analgesia Infusion Pumps, Implantable Infusion Pumps, Other Infusion Pumps |
Key market players worldwide | Baxter International Inc, B. Braun, Medtronic PLC, Micrel Medical Devices, Boston Scientific Corp, Fresenius SE & Co KGaA, Roche Holding AG, Tandem Diabetes Care Inc, Terumo Corp, Moog Inc A, IRadimed Corp, CareFusion, Smiths Group PLC, Mindray Medical International |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to intravenous infusion pumps market will help companies and investors design strategic landscapes.
Volumetric infusion pumps was the largest segment with a revenue share of 16.84% in 2023. Horizon Databook has segmented the Japan intravenous infusion pumps market based on volumetric infusion pumps, syringe infusion pumps, insulin infusion pumps, enteral infusion pumps, ambulatory infusion pumps, patient-controlled analgesia infusion pumps, implantable infusion pumps, other infusion pumps covering the revenue growth of each sub-segment from 2018 to 2030.
There has been an increase in the use of infusion therapy in Japan due to a growth in the number of people requiring medical care each year. The median age in Japan is increasing due to its declining mortality, which has led to an increase in the number of patients suffering from chronic diseases.
Institute of Health Metrics and Evaluation stated that, in 2018, Alzheimer’s was a major cause of death in Japan, accounting for 57% of the total deaths, followed by colorectal cancer, pancreatic cancer, and chronic kidney disease.
According to the Japanese Foundation for Cancer Research, annually, there are about 7,000 cancer surgeries being performed in the country. The aging population in Japan is expected to continue growing until 2040, as stated by the NCBI.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan intravenous infusion pumps market , including forecasts for subscribers. This country databook contains high-level insights into Japan intravenous infusion pumps market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account